SAMPATH WIJESINGHE: Open Payments
NPI 1912216581 · SANGER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,366 in 107 payments from 25 companies in 2025. Trend: 2023 $6,838 · 2024 $1,203 · 2025 $12,366
Speaker / faculty: $7,178Food & beverage: $3,248Travel & lodging: $1,941
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 29 | $10,256 |
| AstraZeneca Pharmaceuticals LP | 4 | $426 |
| ABBVIE INC. | 16 | $313 |
| ViiV Healthcare Company | 13 | $256 |
| Novo Nordisk Inc | 8 | $145 |
| Boston Scientific Corporation | 1 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| Axsome Therapeutics, Inc. | 4 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Amgen Inc. | 4 | $68 |
Products named: Descovy, Yeztugo, AIRSUPRA, VRAYLAR, APRETUDE, General - Therapies, BREZTRI, XIFAXAN.
Industry payments across CA — which companies pay providers there.
